Canopus BioPharma Company Description

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases.

It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals.

The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.

Canopus BioPharma Incorporated

Country	United States
Founded	1996
Industry	Advertising Agencies
Sector	Communication Services
CEO	Patrick Prendergast

Contact Details

Address: 233 Wilshire Boulevard Santa Monica, 90401 United States
Phone	353-627-8674

Stock Details

Ticker Symbol	CBIA
Exchange	OTCMKTS
Stock Type	Common Stock
Reporting Currency	USD
ISIN Number	US1380341032
SIC Code	2834

Key Executives

Name	Position
Patrick T. Prendergast	Chairman and Chief Executive Officer
Leo J. Prendergast	Chief Operating Officer and Director
Andries J. Lategan B.Pharm, M.Sc, Ph.D.	Chief Scientific Officer
Elizabeth Shanahan B.Sc. (Hon)	President of Oncology Division